These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 38663373

  • 1. Potential for Optimization of Growth Hormone Treatment in Children with Growth Hormone Deficiency, Small for Gestational Age, and Turner Syndrome in Germany: Data from the PATRO® Children Study.
    Partsch CJ, Land C, Pfäffle RW, Schwab KO, Sommer H, German PATRO-Board.
    Horm Res Paediatr; 2024 Apr 25; ():1-11. PubMed ID: 38663373
    [Abstract] [Full Text] [Related]

  • 2. Still too little, too late? Ten years of growth hormone therapy baseline data from the NordiNet® International Outcome Study.
    Polak M, Konrad D, Tønnes Pedersen B, Puras G, Šnajderová M.
    J Pediatr Endocrinol Metab; 2018 Apr 25; 31(5):521-532. PubMed ID: 29652668
    [Abstract] [Full Text] [Related]

  • 3. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A, Daftardar H, Alghamdi AA, Jamjoom M, Awidah S, Ahmed ME, Soliman AT.
    Acta Biomed; 2020 Mar 19; 91(1):29-40. PubMed ID: 32191651
    [Abstract] [Full Text] [Related]

  • 4. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.
    Horm Res; 2005 Mar 19; 64(2):68-76. PubMed ID: 16113581
    [Abstract] [Full Text] [Related]

  • 5. Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study.
    Blankenstein O, Snajderova M, Blair J, Pournara E, Pedersen BT, Petit IO.
    Eur J Endocrinol; 2017 Aug 19; 177(2):145-155. PubMed ID: 28522645
    [Abstract] [Full Text] [Related]

  • 6. Changes in body proportions and body fat content in GH-deficient and non-GH-deficient children during the first year of growth hormone treatment.
    Majcher A, Rumińska M, Witkowska-Sędek E, Paluchowska M, Krajewska M, Artemniak-Wojtowicz D, Pyrżak B.
    Anthropol Anz; 2024 Jun 24. PubMed ID: 38912850
    [Abstract] [Full Text] [Related]

  • 7. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F, Ranke MB, Bakker B, Lindberg A, Cowell CT, Albertsson-Wikland K, Reiter EO, Price DA.
    Horm Res; 2005 Jun 24; 63(1):40-7. PubMed ID: 15627781
    [Abstract] [Full Text] [Related]

  • 8. [Growth Hormone treatment in children with Growth Hormone deficiency, idiopathic short stature, SHOX gene mutation, small for gestational age and Turner syndrome].
    Griffero González M, González Navarrete D, Tolosa Navarro F, López Cuevas P, Rodríguez Convertino F, Román Reyes R.
    Andes Pediatr; 2024 Apr 24; 95(2):151-158. PubMed ID: 38801362
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of Clinical Features and Growth Hormone Deficiency in Short Children Born Small For Gestational Age].
    Ikegami T, Araki S, Kuwamura M, Taku A, Saito R, Goto M, Kubo K, Kawagoe R, Yamamoto Y, Kawada Y, Kusuhara K.
    J UOEH; 2018 Apr 24; 40(3):253-257. PubMed ID: 30224622
    [Abstract] [Full Text] [Related]

  • 10. Safety and Effectiveness of Omnitrope®, a Biosimilar Recombinant Human Growth Hormone: More Than 10 Years' Experience from the PATRO Children Study.
    Pfäffle R, Bidlingmaier M, Kreitschmann-Andermahr I, Land C, Partsch CJ, Schwab KO, Sommer H, Backeljauw P, Kanumakala S, Loche S, Zouater H, Strasburger CJ.
    Horm Res Paediatr; 2020 Apr 24; 93(3):154-163. PubMed ID: 32814319
    [Abstract] [Full Text] [Related]

  • 11. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
    Blanco-López A, Antillón-Ferreira C, Saavedra-Castillo E, Barrientos-Pérez M, Rivero-Escalante H, Flores-Caloca O, Calzada-León R, Rosas-Guerra CC, Koledova E, Chiquete E, Ayala-Estrada A.
    J Endocrinol Invest; 2020 Oct 24; 43(10):1447-1452. PubMed ID: 32239476
    [Abstract] [Full Text] [Related]

  • 12. The long-term growth, cost-effectiveness, and glycemic effects of growth hormone therapy on children born small for gestational age over 10 years: a retrospective cohort study.
    Al Khalifah RA, Alhakami A, AlRuthia Y, Al Sarraj HZ, Abulqasim J, Al-Rasheedi A, NurHussen A, Naji A.
    J Pediatr Endocrinol Metab; 2022 Nov 25; 35(11):1357-1368. PubMed ID: 36203313
    [Abstract] [Full Text] [Related]

  • 13. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G, Baur F, Schweizer R, Ranke MB.
    J Clin Endocrinol Metab; 2006 Feb 25; 91(2):659-64. PubMed ID: 16291706
    [Abstract] [Full Text] [Related]

  • 14. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
    Takeda A, Cooper K, Bird A, Baxter L, Frampton GK, Gospodarevskaya E, Welch K, Bryant J.
    Health Technol Assess; 2010 Sep 25; 14(42):1-209, iii-iv. PubMed ID: 20849734
    [Abstract] [Full Text] [Related]

  • 15. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ, Boonstra VH, Mulder PG, Odink RJ, Stokvis-Brantsma WH, Rongen-Westerlaken C, Mulder JC, Delemarre-Van de Waal H, Reeser HM, Jansen M, Waelkens JJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2003 Dec 25; 59(6):779-87. PubMed ID: 14974922
    [Abstract] [Full Text] [Related]

  • 16. Serum leptin in short children born small for gestational age: relationship with the growth response to growth hormone treatment. The Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M, Dahlgren J, Bjarnason R, Rosberg S, Carlsson LM, Carlsson B, Albertsson-Wikland K.
    Eur J Endocrinol; 1997 Oct 25; 137(4):387-95. PubMed ID: 9368507
    [Abstract] [Full Text] [Related]

  • 17. An observational study of the effectiveness and safety of growth hormone (Humatrope(®)) treatment in Japanese children with growth hormone deficiency or Turner syndrome.
    Tai S, Tanaka T, Hasegawa T, Ozono K, Tanaka H, Kanzaki S, Yokoya S, Fujieda K, Chihara K, Seino Y.
    Endocr J; 2013 Oct 25; 60(1):57-64. PubMed ID: 23001148
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.